Found: 7
Select item for more details and to access through your institution.
BMPR2‐expressing bone marrow‐derived endothelial‐like progenitor cells alleviate pulmonary arterial hypertension in vivo.
- Published in:
- Respirology, 2019, v. 24, n. 11, p. 1095, doi. 10.1111/resp.13552
- By:
- Publication type:
- Article
Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 3, p. 259, doi. 10.1007/s00281-022-00925-9
- By:
- Publication type:
- Article
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43039-y
- By:
- Publication type:
- Article
Mast cell activation and degranulation in acute artery injury: A target for post‐operative therapy.
- Published in:
- FASEB Journal, 2023, v. 37, n. 7, p. 1, doi. 10.1096/fj.202201745RR
- By:
- Publication type:
- Article
BMPR2 gene therapy for PAH acts via Smad and non- Smad signalling.
- Published in:
- Respirology, 2016, v. 21, n. 4, p. 727, doi. 10.1111/resp.12729
- By:
- Publication type:
- Article
BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
- Published in:
- Respirology, 2016, v. 21, n. 3, p. 526, doi. 10.1111/resp.12712
- By:
- Publication type:
- Article
iPSC–endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 592, p. 1, doi. 10.1126/scitranslmed.aba6480
- By:
- Publication type:
- Article